Skip to main content
# Title Department Research Member Research Year
71 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Hadeer Mohamed Saad Elshazly 2024
72 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2024
73 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024
74 Pediatric cancer mortality: Analyzing early deaths and fatalities in a resource-limited tertiary care context Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2024
75 Contrast enhanced digital mammography as a predictor of breast cancer in patient with pathological nipple discharge Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2024
76 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Department of Pathology Amira Emad Mohamed Elwy 2024
77 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Dr. Doaa Mohamed Fouad Mahmoud 2024
78 Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer Department of Medical Oncology Zeina Omar Attia Sayed 2024
79 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2024
80 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Amany Mohammed Abdel Moatamed 2024